+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Dr Tim Meyer
MD, BSc, PhD, FRCP
Hepatobiliary and/or pancreatic cancers
Neuroendocrine Cancers and Anti-body based therapy
Dr Tim Meyer is a Medical Oncologist with a special interest in antibody based therapies. He trained at UCLH Medical School and obtained a PhD in Cancer Biology from the University of London before completing his specialist training in Medical Oncology. He was appointed Senior Lecturer at UCL in 2002 and is now based in the UCL Cancer Institute where he leads a team focussed on clinical research and developing new drugs to treat cancer. Recent work includes the use of antibodies to target radiotherapy to cancer cells he is currently working on a new antibody based therapy which can be applied to cervical cancer.
To Make an appointment, call HCA on +44(0)20 7079 4399
or click here
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.